Clinical implications of ultrasonography in monitoring disease activity of relapsing polychondritis

Rheumatology (Oxford). 2016 Jul;55(7):1250. doi: 10.1093/rheumatology/kew219. Epub 2016 May 3.

Authors

Yoshinori Taniguchi¹, Hirofumi Nishikawa², Shuichi Nakayama², Eri Amano², Yoshio Terada²

Affiliations

¹ Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Kochi, Japan taniguchiy@kochi-u.ac.jp.
² Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Kochi, Japan.

PMID: 27143790
DOI: 10.1093/rheumatology/kew219

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Drug Therapy, Combination
Ear Auricle / diagnostic imaging*
Ear Auricle / pathology
Ear Diseases / diagnostic imaging*
Ear Diseases / drug therapy
Ear Diseases / pathology
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Male
Methotrexate / therapeutic use
Polychondritis, Relapsing / diagnostic imaging*
Polychondritis, Relapsing / drug therapy
Polychondritis, Relapsing / pathology
Prednisolone / therapeutic use
Ultrasonography

Substances

Glucocorticoids
Immunosuppressive Agents
Prednisolone
Methotrexate